Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Alexion Pharmaceuticals Inc (ALXN)

NASDAQ
Currency in USD
Disclaimer
182.50
0.00(0.00%)
Closed

ALXN Comments

Give the anti-corona spray from marinomed-biotech some VC and invest in a pharma company which is heading to the moon:https://www.investing.com/equities/marinomed-biotech-agStudies are proving that the patented method of marinomed prevents infection with all Corona varietis including mutants. It also prevents other virus infections. They have many patents.  Do some good and get rich
ATVI, Nio, Li and Fcel will be very good shares to buy and hold.. 30% to 60% gain gradually soon..
Currently this should trading st about 166-167, due to the buyout. Seems like market here is off by in ballbark of 10.
market is pricing risk of deal not going through, thats why astrazenca plummeted today
Ok, ty, i thought as much
 Even if the deal doesn't go throught, alexion is still a compagny to buy
Shouldnt it be trading at around 167 atm. ?
 AZN?
Astrazeneca
 Ya brain farted lol, was having lunch
still needs to go to atleast177 to represent the new marketcap of 39 bill after the sale.
TUSK double the price very soon..Very low volume.. Easy to jump.. Don't miss it.. Good luck guys..
why is this stock rising if it was sold
Astra buys Alexion for a share price of $175
only 60 is money rest AZN shares. Deal can go bust also and AZN share price is down 5pros so pris is buying price is down like 3pros. If deal goes sauer Alexion will go under original price fast and hard.
AstraZeneca is buying this, what is next? (read article)
Long tp 165
they buy it at share price around 175$, shareholders get AstraZeneca shares and a premium too
Cocrystal Pharma, Inc. (COCP), up 45%
seems extremely undervalued and yet no takers? can anyone explain?
if you check the historical fundamentals I agree, it seems to be very undervalued. BUT the earnings depends strongly of a very expensive drug for a rare disease and concurrents have fund a less expensive efficacious drug for the same disease.
You were right. Its 31 aug today and the price just increased by alot.
Waiting for low $90s, may be another shot there. It's not about what you think is undervalued, it's about what market thinks.
what is good for week position?
buy for ALXN?
strong balance sheet
what's going on?
Nobody knows actually
trash
why?
i think ALXN is one of the best in its industry
5
Strong buy
 amazing financials and strong growth in years. Stock is one of the most undervalued on the entire market
 analysts average 12 months target price: 144$ (44% up)
cool. Are you gonna sit in this comment section for 12 months?
Any real thoughts on Alexion
I got a deep thoughts but guess we cant upload POC here
point of contacy
t*
Simply got into sh... company.
They lost their patent in 2017 for the eculizumab or soliris, the drug which is now being tested.
Will these guys launch covid-19 vaccine attempt announcement?
Run away from here !
idling at 114.40
What happened? Down 6.6%.
a lot competitor getting close
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.